Hundred Finance USD Price & Performance (HNDUSD)

After a decade-long hiatus, India and New Zealand have announced the restart of talks for a Free Trade Agreement (FTA). This initiative aims to enhance bilateral trade, which has already surpassed $1 billion in the current fiscal year. The discussions focus on improving supply chain integration and market access.1

Sun Pharma and Zydus Pharmaceuticals are recalling specific drugs from the US market due to manufacturing issues. Sun Pharma's morphine tablets failed dissolution tests, while Zydus cited impurities in its Nelarabine injection. Both recalls, classified as Class II, highlight ongoing quality concerns in pharmaceutical manufacturing.2

India is positioning itself as a semiconductor hub, leveraging fiscal incentives, low production costs, and strategic partnerships. With over $18 billion in investments underway, including Tata Electronics' collaboration with PSMC, the sector is expected to create 80,000 jobs. The government aims to quadruple electronics production by 2030.3